# FDA Inspection 1298396 - US Specialty Formulations LLC - January 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/e72c419c-3eb9-4794-a8df-38ab824d37c6
Source feed: FDA_Inspections

> FDA Inspection 1298396 for US Specialty Formulations LLC on January 14, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298396
- Company Name: US Specialty Formulations LLC
- Inspection Date: 2026-01-14
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1265449 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/e25bcef3-888a-4f3e-b64b-223257e43fa2)
- [FDA Inspection 1243882 - 2024-07-02](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/dd9ee101-2a34-4453-ad4e-ba79c9bf11c3)
- [FDA Inspection 1167934 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/737bef48-423a-4dcc-92af-ca91074c2095)
- [FDA Inspection 1167934 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/c2529d65-9b9a-4df4-95ab-aed2f8190c7d)
- [FDA Inspection 1097950 - 2019-07-23](https://www.keypedia.com/records/fda_inspections/us-specialty-formulations-llc/d3651a69-ca0b-4e10-a392-9496baabe17c)

Company: https://www.keypedia.com/companies/us-specialty-formulations-llc/2a5dd57a-6a0b-44a4-88ec-d642f91d1315

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8